Hbk Sorce Advisory LLC Editas Medicine, Inc. Transaction History

Hbk Sorce Advisory LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$26.55 - $40.57 $131,475 - $200,902	-4,952 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $5,772 - $10,722	147 Added 3.06%	4,952 $203,000
Q2 2021 Aug 12, 2021	BUY	$31.29 - $56.64 $150,348 - $272,155	4,805 New	4,805 $272,000
Q4 2018 Feb 14, 2019	SELL	$18.19 - $31.79 $116,088 - $202,883	-6,382 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$27.65 - $38.39 $176,462 - $245,004	6,382 New	6,382 $203,000

244

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.